Company Info
Profound Medical Corp. is a Canadian medical technology company focused on developing and commercializing innovative and minimally invasive treatments for patients with prostate disease, uterine fibroids, and other conditions. The company's core technology, known as TULSA-PRO®, combines real-time MRI, robotically-driven transurethral ultrasound, and closed-loop temperature feedback control to deliver precise and customizable thermal ablation of targeted tissue. Profound Medical is dedicated to improving patient outcomes and providing healthcare providers with advanced tools for effective treatment. The company is headquartered in Mississauga, Ontario, and is listed on the TSX (Toronto Stock Exchange) under the ticker symbol "PRN" and on the NASDAQ under "PROF."